CircPSMC3 inhibits cell proliferation and induces cell apoptosis in nasopharyngeal carcinoma by downregulating ROCK1

D-Q Guo1, F Liu, L Zhang

  • 1Department of Otolaryngology Head and Neck Surgery, People's Liberation Army Hospital 960 Ziboyuan District, Zibo, China.

Insights

This article on circPSMC3 and nasopharyngeal carcinoma has been withdrawn due to suspected research misconduct. The publisher retracted the study after authors failed to prove data originality.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Nasopharyngeal carcinoma (NPC) is a significant health concern.
  • Understanding the molecular mechanisms underlying NPC progression is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of circular RNA PSMC3 (circPSMC3) in nasopharyngeal carcinoma.
  • To explore the potential of circPSMC3 as a therapeutic target.

Main Methods:

  • The study aimed to analyze the expression and function of circPSMC3 in NPC.
  • Investigated the interaction between circPSMC3 and ROCK1.

Main Results:

  • The original study suggested circPSMC3 inhibits cell proliferation and induces apoptosis in NPC.
  • It was proposed that circPSMC3 downregulates ROCK1 expression.

Conclusions:

  • The findings indicated circPSMC3 as a potential tumor suppressor in NPC.
  • The study suggested a novel regulatory pathway involving circPSMC3 and ROCK1 in NPC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.3K